Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Torrent Pharma Gets FDA Tentative Approval for Memantine Pill

Sept. 30 (Bloomberg) -- Indian drugmaker Torrent Pharmaceuticals Ltd. received tentative approval from the U.S. Food and Drug Administration for its memantine hydrochloride pill, the generic version of Forest Laboratories Inc.’s Namenda medicine to treat Alzheimer’s disease, according to a statement on the regulator’s website.

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{FRX US <Equity> CN <GO>} Link to Company News:{TRP IN <Equity> CN <GO>}

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Niveditha Ravi at nravi2@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.